A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
Abstract Background Anthracycline usage has been linked to cardiovascular adverse events (CAEs), which is unpredictable. It is critical to identify the characteristics of vulnerable populations and risk factors in order to reduce the occurrence of CAEs. Objectives This meta-analysis aimed to assess...
Saved in:
Main Authors: | Bo Dai, Jingjing Xu, Baiyan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-024-13305-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials
by: Zhao M, et al.
Published: (2025-01-01) -
Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
by: Chien‐Wei Huang, et al.
Published: (2025-02-01) -
Visit-to-visit lipid variability on long-term major adverse cardiovascular events: a prospective multicentre cohort from the CORE-Thailand registry
by: Chutithep Teekaput, et al.
Published: (2025-01-01) -
Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
by: Koichi Egashira, et al.
Published: (2022-06-01) -
Association between cardiopulmonary bypass duration and early major adverse cardiovascular events after surgical repair of supravalvular aortic stenosis
by: Simeng Zhang, et al.
Published: (2025-01-01)